Model Lee Hyun-yi confessed that she was diagnosed with narcolepsy, a rare and intractable disease.According to the Health ...

Samelisant (SUVNG-3031) is under development for the treatment of narcolepsy with and without cataplexy and cognitive disorders. The drug candidate is administered orally in the form of tablet. The ...

Jazz's neuroscience franchise faces declining Xyrem sales but sees growth in Xywav and Epidiolex. Oncology growth is driven ...

The global Narcolepsy market is expected to reach $4.68 billion by 2031 and the global Idiopathic Hypersomnia treatment ...

Money Marketing's Weekend Essays are a chance to break away from the topics we write about every day and look into something ...

Drivers who fail to report excessive sleepiness conditions to the DVLA could face fines of up to £1,000 and potential ...

People who live with narcolepsy — about one out of every 2,000 Americans — don’t have many options when it comes to treatment. The milder form of narcolepsy includes symptoms of excessive ...

Various medications that treat narcolepsy are available, and treatment plans can vary based on individual symptoms and other factors. Healthcare providers often start with one medication but may need ...

Prolong periods of bad sleep can lead to a myriad of health issues like memory problems, fatigue, poor balance and increased ...

The narcolepsy treatment market trends is estimated to reach USD 5,301.6 million in 2024. It is estimated that revenue will increase at a CAGR of 5.1% between 2024 and 2034. The market is anticipated ...

Avadel Pharmaceuticals plc (NASDAQ:AVDL – Get Free Report) has been given an average recommendation of “Buy” by the seven research firms that are presently covering the stock, Marketbeat reports.

According to Statistics Canada, 25 per cent of Canadians are "dissatisfied" with their sleep. And some clinicians say the ...